Julia Martinez-Sanchez
Overview
Explore the profile of Julia Martinez-Sanchez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramos A, Youssef L, Molina P, Martinez-Sanchez J, Moreno-Castano A, Blasco M, et al.
Acta Obstet Gynecol Scand
. 2025 Feb;
PMID: 40007223
Introduction: Our objective was to evaluate the endothelial function profile and complement system in fetuses from preeclamptic pregnancies using ex vivo and in vitro approaches. Material And Methods: A total...
2.
De Moner B, Martinez-Sanchez J, Garrote M, Ramos A, Ventosa-Capell H, Moreno-Castano A, et al.
Thromb Haemost
. 2025 Jan;
PMID: 39809451
Background: V617F-mutated myeloproliferative neoplasms (MPN) exhibit abnormal proliferation of bone marrow progenitors and increased risk of thrombosis, specifically in splanchnic veins (SVT). The contribution of the endothelium to the development...
3.
Ramos A, Youssef L, Molina P, Torramade-Moix S, Martinez-Sanchez J, Moreno-Castano A, et al.
Front Immunol
. 2024 Dec;
15:1488127.
PMID: 39735539
Background: Preeclampsia (PE) is a pregnancy complication characterized by hypertension, proteinuria, endothelial dysfunction, and complement dysregulation. Placenta-derived extracellular vesicles (EVs), necessary in maternal-fetal communication, might contribute to PE pathogenesis. Moreover,...
4.
Martinez-Sanchez J, Torramade-Moix S, Moreno-Castano A, Llobet D, Jerez-Dolz D, Sanchez P, et al.
TH Open
. 2024 Dec;
8(4):e329-e339.
PMID: 39619107
Association between global platelet function and the risk of venous thromboembolic disease (VTE) has been proposed, though the mechanisms do not involve increased platelet aggregation. However, platelet adhesiveness has not...
5.
Escribano-Serrat S, Pedraza A, Suarez-Lledo M, Charry P, De Moner B, Martinez-Sanchez J, et al.
Bone Marrow Transplant
. 2024 Aug;
59(10):1466-1476.
PMID: 39117736
Since 2021 the use of G-CSF was implemented in allo-HCT with PTCY-based prophylaxis with the aim of shortening the aplastic phase and reducing infectious complications. This study investigates the effectiveness...
6.
Tolosa-Ridao C, Cascos E, Rodriguez-Lobato L, Pedraza A, Suarez-Lledo M, Charry P, et al.
Bone Marrow Transplant
. 2024 Mar;
59(7):974-982.
PMID: 38521885
This study investigates the interaction between endothelial activation, indirectly measured using EASIX, and the probability of presenting cardiac adverse events (CAE) during the first year after allo-HCT. The 437 consecutive...
7.
Martinez-Sanchez J, Castrillo L, Jerez D, Torramade-Moix S, Palomo M, Mendieta G, et al.
Sci Rep
. 2023 Dec;
13(1):22969.
PMID: 38151494
We evaluated modifications in the hemostatic balance of different concentrations of apixaban (APIX) in 25 healthy donors and 53 patients treated with aspirin (ASA, n = 21), ASA and clopidogrel...
8.
Samanbar S, Pineyroa J, Moreno-Castano A, Pino M, Torramade-Moix S, Martinez-Sanchez J, et al.
Blood Transfus
. 2023 Dec;
22(2):166-175.
PMID: 38063791
Background: Current laboratory tests fail to evaluate the hemostatic function of platelets in patients with thrombocytopenia. We investigated the use of the Total Thrombus-Formation Analysis System (T-TAS 01 [Fujimori Kogyo...
9.
Palomo M, Moreno-Castano A, Salas M, Escribano-Serrat S, Rovira M, Guillen-Olmos E, et al.
Front Med (Lausanne)
. 2023 Nov;
10:1285898.
PMID: 38034541
The endothelium is a biologically active interface with multiple functions, some of them common throughout the vascular tree, and others that depend on its anatomical location. Endothelial cells are continually...
10.
Moreno-Castano A, Fernandez S, Ventosa H, Palomo M, Martinez-Sanchez J, Ramos A, et al.
J Immunother Cancer
. 2023 Apr;
11(4).
PMID: 37045474
Background: Chimeric antigen receptor (CAR)-T cell-based immunotherapy constitutes a revolutionary advance for treatment of relapsed/refractory hematological malignancies. Nevertheless, cytokine release and immune effector cell-associated neurotoxicity syndromes are life-threatening toxicities in...